1 / 19

2008 International Symposium on Pharmaceuticals in the Home

2008 International Symposium on Pharmaceuticals in the Home. PMP/TDS Update Debra Brucker, M.P.A., Ph.D. Daniel Eccher, M.P.H. Maine Office of Substance Abuse. PMP Overview. Data collection began July 1, 2004 Data submitted by over 300 pharmacies in and out of state

duc
Download Presentation

2008 International Symposium on Pharmaceuticals in the Home

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2008 International Symposium on Pharmaceuticals in the Home PMP/TDS Update Debra Brucker, M.P.A., Ph.D. Daniel Eccher, M.P.H. Maine Office of Substance Abuse

  2. PMP Overview • Data collection began July 1, 2004 • Data submitted by over 300 pharmacies in and out of state • DEA Schedules II, III, and IV • Patient-specific data directly accessible to a select few people (e.g., physicians) • Intent: health care tool for reducing accessibility of controlled substances for non-medical use

  3. PMP Limitations • Accuracy and completeness of data up to pharmacies • Many new data submitters came online in 2008 • No unique identifiers; no legal ID requirement • Prescriptions written for various time periods and quantities – best way to analyze unknown

  4. Overall CS Counts SFY08

  5. Tranquilizer Rx Counts SFY08

  6. Lorazepam by Age GroupMaine Patients, SFY 2008

  7. ClonazepamMaine Patients, SFY 2008

  8. AlprazolamMaine Patients, SFY 2008

  9. DiazepamMaine Patients, SFY 2008

  10. Benzodiazepine Rx Counts: TrendsMaine Patients, 2004 - 2008

  11. All Benzodiazepines, Maine Pts.

  12. “Top 5” Benzos by Rx Count (Maine Patients, 2004 - 2008)

  13. “Top 5” Benzos by Rx Count (Maine Patients, 2004 - 2008)

  14. Treatment Data System (TDS) • Data submitted to OSA by substance abuse treatment providers throughout Maine • Government-funded programs required • Some privately funded programs voluntarily submit • Monthly checks on accuracy and completeness of data • Comprehensive picture of SA treatment in Maine

  15. Admissions to Treatment:Primary Drug = Benzodiazepine

  16. Admissions to Treatment:Secondary Drug = Benzodiazepine

  17. Admissions to Treatment:Tertiary Drug = Benzodiazepine

  18. Treatment Admissions by Primary Drug, 1999 - 2008

  19. Questions? debra.brucker@maine.gov daniel.eccher@maine.gov http://www.maine.gov/dhhs/osa/data (207) 287-2595

More Related